Microbot Medical Stock Forecast, Price & News

-0.02 (-0.25 %)
(As of 04/14/2021 12:00 AM ET)
Today's Range
Now: $7.91
50-Day Range
MA: $8.39
52-Week Range
Now: $7.91
Volume83,025 shs
Average Volume163,453 shs
Market Capitalization$56.22 million
P/E RatioN/A
Dividend YieldN/A
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Microbot Medical logo

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolNASDAQ:MBOT
Year FoundedN/A



Sales & Book Value

Annual SalesN/A
Book Value$5.02 per share


Net Income$-7,250,000.00


Market Cap$56.22 million
Next Earnings Date5/21/2021 (Estimated)
OptionableNot Optionable


Stock Alert: Microbot Medical Spikes 25%
August 17, 2020 |
See More Headlines


Overall MarketRank

1.26 out of 5 stars

Medical Sector

854th out of 2,020 stocks

Biological Products, Except Diagnostic Industry

118th out of 177 stocks

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
-0.02 (-0.25 %)
(As of 04/14/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MBOT News and Ratings via Email

Sign-up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions

Is Microbot Medical a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Microbot Medical stock.
View analyst ratings for Microbot Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Microbot Medical?

Wall Street analysts have given Microbot Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Microbot Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Microbot Medical?

Microbot Medical saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 367,300 shares, a decline of 17.7% from the March 15th total of 446,400 shares. Based on an average daily volume of 164,400 shares, the days-to-cover ratio is currently 2.2 days.
View Microbot Medical's Short Interest

When is Microbot Medical's next earnings date?

Microbot Medical is scheduled to release its next quarterly earnings announcement on Friday, May 21st 2021.
View our earnings forecast for Microbot Medical

How were Microbot Medical's earnings last quarter?

Microbot Medical Inc. (NASDAQ:MBOT) announced its quarterly earnings results on Tuesday, March, 30th. The biotechnology company reported ($0.37) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.03.
View Microbot Medical's earnings history

How has Microbot Medical's stock price been impacted by COVID-19?

Microbot Medical's stock was trading at $6.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MBOT stock has increased by 24.0% and is now trading at $7.91.
View which stocks have been most impacted by COVID-19

When did Microbot Medical's stock split? How did Microbot Medical's stock split work?

Microbot Medical shares reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.

What price target have analysts set for MBOT?

1 brokerages have issued twelve-month price targets for Microbot Medical's shares. Their forecasts range from $20.00 to $20.00. On average, they expect Microbot Medical's share price to reach $20.00 in the next twelve months. This suggests a possible upside of 152.8% from the stock's current price.
View analysts' price targets for Microbot Medical
or view top-rated stocks among Wall Street analysts.

Who are Microbot Medical's key executives?

Microbot Medical's management team includes the following people:
  • Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 48, Pay $517.8k)
  • Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 52, Pay $74.27k)
  • Prof. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 69)
  • Dr. Simon Sharon, CTO & Chairman of Scientific Advisory Board
  • Dr. Eric C. Leuthardt, Scientific Director & Member of Scientific Advisory Board
  • Dr. Eyal Morag M.D., Chief Medical Officer (Age 55)

Who are some of Microbot Medical's key competitors?

What other stocks do shareholders of Microbot Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), Micron Technology (MU) and Sorrento Therapeutics (SRNE).

What is Microbot Medical's stock symbol?

Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."

How do I buy shares of Microbot Medical?

Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Microbot Medical's stock price today?

One share of MBOT stock can currently be purchased for approximately $7.91.

How much money does Microbot Medical make?

Microbot Medical has a market capitalization of $56.22 million.

How many employees does Microbot Medical have?

Microbot Medical employs 10 workers across the globe.

What is Microbot Medical's official website?

The official website for Microbot Medical is

Where are Microbot Medical's headquarters?

Microbot Medical is headquartered at 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043.

How can I contact Microbot Medical?

Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected]

This page was last updated on 4/15/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.